An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
Titel:
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
Auteur:
Moehler, M. Mueller, A. Hartmann, J.T. Ebert, M.P. Al-Batran, S.E. Reimer, P. Weihrauch, M. Lordick, F. Trarbach, T. Biesterfeld, S. Kabisch, M. Wachtlin, D. Galle, P.R.